(1)
Portal Hypertension After Prolonged Use of Trastuzumab Emtansine: Nodular Regenerative Hyperplasia With Autoimmune Features. RSD 2021, 10 (8), e10810817005. https://doi.org/10.33448/rsd-v10i8.17005.